---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-028821"
form_type: "8-K"
ticker: "MRKR"
cik: "0001094038"
company_name: "Marker Therapeutics, Inc."
filed_at: "2025-03-27T23:59:59+00:00"
generated_at: "2026-05-24T03:38:18.876899+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Marker Therapeutics stockholders approve issuance of 8.28M warrant shares

## Summary
- At special meeting on March 21, 2025, 4,158,543 shares (38.83% of outstanding) represented.
- Proposal passed: 3,483,897 for, 668,383 against, 6,263 abstained.
- Approves issuance of up to 5,031,250 shares under Series A Warrants and 3,247,445 under Series B Warrants.
- Total authorized warrant shares: 8,278,695, approximately 77% of 10.7M outstanding shares.

## SEC filing metadata
- accession: 0001104659-25-028821
- form_type: 8-K
- ticker: MRKR
- cik: 0001094038
- company_name: Marker Therapeutics, Inc.
- filed_at: 2025-03-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.85
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1094038/000110465925028821/0001104659-25-028821-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1094038/000110465925028821/tm2510592d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-028821
- JSON: https://secwatch.observer/filing/0001104659-25-028821.json
- Plain text: https://secwatch.observer/filing/0001104659-25-028821.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.